 provide technical support in the analysis of study drugs. Research: In the last 10 years, patients have markedly increased their use of dietary supplements to treat and prevent chronic medical conditions like atherosclerotic cardiovascular disease. This widespread use continues despite little scientific evidence of benefit from randomized controlled trials (RCTs). Current estimates suggest that 30 percent
provide technical support in the analysis of study drug. inquiry: In the concluding 10 years, patients have markedly increase their use of dietary supplements to process and prevent chronic medical conditions like atherosclerotic cardiovascular disease. This far-flung habit continues despite short scientific evidence of benefit from randomized controlled trial (RCTs). Current estimates indicate that 30 percent
 prlvide technical support ln the analysis of studb drugs. Researcf: In the last 10 years, patientd yave narkedly increased thekr use of dietary supklements to treat and preyznt cgvonic nedical conditlons like adherosclerotic cxrbiovascular disease. This widespread tse conyijues despite lyttlt ssienfpflc evidence of benefit from randkmized bontrolled trials (RCTs). Current estimates suhgesh that 30 percent
provide technical support in the analysis of Research: the last years, patients have dietary to treat and chronic medical conditions atherosclerotic cardiovascular disease. This widespread use despite little scientific evidence of benefit from randomized controlled trials (RCTs). Current estimates that 30 percent
 provide technical support in The analysiS of stUdy DruGs. reseArch: in the last 10 years, PAtieNts have markedly increasEd theIr USe of DIeTary sUpplemeNTs TO TreAt AnD prEvENt ChronIc mEdical cOnditions lIke AtHerosclerotiC CaRdiovasculAr dIsease. This wiDesPread uSe ConTInues DesPite lIttle sCIentifIc evidencE oF BenefiT From ranDOMiZed cOntrolled trials (RCtS). CURrent estimates SuggesT tHAt 30 PERceNt
 provide technical support  in the an alysi s o f s tu dy d rugs . Research: In thelast 10 years, patient s hav em arke d ly  incr eased t h ei r use  o fdie ta r ysuppl eme nts totreat andpre ve nt chronic m e di cal condit ion s like ather osc leroti ccar d iovas cul ar di sease. This w idespread  u s e cont i nues de s p it e li ttle scientific e v id e nce of benefit  fromra n do m i zed  co ntrolled t ri als ( R CTs). C u rr e n t  es t imates sugges t that 30 p e rce nt
 provide_technical support_in the analysis of_study drugs._Research:_In the_last_10 years, patients_have markedly increased_their use of dietary_supplements to treat_and_prevent chronic medical conditions like atherosclerotic cardiovascular disease. This widespread use continues despite little_scientific_evidence of_benefit_from_randomized controlled trials (RCTs). Current_estimates suggest that 30 percent